The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Qing Liu; Stig Bengmark; Shen Qu
January 2010
Lipids in Health & Disease;2010, Vol. 9, p42
Academic Journal
Nonalcoholic fatty liver disease is increasingly regarded as a hepatic manifestation of metabolic syndrome, and the severity of nonalcoholic fatty liver disease seems to increase in parallel with other features of metabolic syndrome. Excess lipid accumulation in the liver cells is not only a mediator of Metabolic Syndrome and indicator of a lipid overload but also accompanied by a range of histological alterations varying from 'simple' steatosis to nonalcoholic steatohepatitis, with time progressing to manifest cirrhosis. Hepatocellular carcinoma may also occur in nonalcoholic steatohepatitis -related cirrhosis with a mortality rate similar to or worse than for cirrhosis associated with hepatitis C. This review summarizes the knowledge about the causal relationship between hepatic fat accumulation, insulin resistance, liver damage and the etiological role of hepatic fat accumulation in pathogenesis of extra- and intra-hepatic manifestations. Special emphasis is given suggestions of new targets treatment and prevention of nonalcoholic fatty liver disease.


Related Articles

  • NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Enjoji, Munechika; Machida, Kazuyuki; Kohjima, Motoyuki; Kato, Masaki; Kotoh, Kazuhiro; Matsunaga, Kazuhisa; Nakashima, Manabu; Nakamuta, Makoto // Lipids in Health & Disease;2010, Vol. 9, p29 

    Background: We recently examined the distribution of abdominal fat, dietary intake and biochemical data in patients with nonalcoholic fatty liver disease (NAFLD) and found that non-obese NAFLD patients did not necessarily exhibit insulin resistance and/or dysregulated secretion of...

  • The Fatty Liver and Insulin Resistance. Yki-Järvinen, H.; Westerbacka, J. // Current Molecular Medicine;May2005, Vol. 5 Issue 3, p287 

    Obesity is not necessary to observe insulin resistance in humans since severe insulin resistance also characterizes patients lacking subcutaneous fat such as those with HAART (highlyactive antiretroviral therapy) - associated lipodystrophy. Both the obese and the lipodystrophic patients have,...

  • Pathogenesis of non-alcoholic fatty liver disease. DOWMAN, J. K.; TOMLINSON, J. W.; NEWSOME, P. N. // QJM: An International Journal of Medicine;Feb2010, Vol. 103 Issue 2, p71 

    The article discusses the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Although this disease can be experienced by all ethnic groups, there seems to have a lower prevalence rate in African Americans when compared to Hispanic and European Americans. NAFLD is often linked to features...

  • Estrogen Treatment After Ovariectomy Protects Against Fatty Liver and May Improve Pathway-Selective Insulin Resistance. Lin Zhu; Brown, William C.; Qing Cai; Krust, Andrée; Chambon, Pierre; McGuinness, Owen P.; Stafford, John M. // Diabetes;Feb2013, Vol. 62 Issue 2, p425 

    Pathway-selective insulin resistance where insulin fails to suppress hepatic glucose production but promotes liver fat storage may underlie glucose and lipid abnormalities after menopause. We tested the mechanisms by which estrogen treatment may alter the impact of a high-fat diet (HFD) when...

  • Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD). Poonam Mishra; Zobair M. Younossi // Current Drug Discovery Technologies;Sep2007, Vol. 4 Issue 2, p133 

    Nonalcoholic fatty liver disease (NAFLD) is recognized as the most common cause of chronic liver disease worldwide. NAFLD is a clinicopathologic syndrome ranging from simple steatosis, which is relatively benign, to the more severe form known as nonalcoholic steatohepatitis (NASH), which may...

  • NAFLD: NEED FOR A MORE AGGRESSIVE APPROACH.  // Gut;Apr2004 Supplement 3, Vol. 53, pA83 

    Non-alcoholic fatty liver disease (NAFLD} is a disease of emerging importance. It is associated with the metabolic syndrome comprising obesity, insulin resistance, hyperlipidaemia and hypertension. The pathophysiology involves two steps: insulin resistance causing steatosis followed by oxidative...

  • Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Ying Qin; Ya-ping Tian // Lipids in Health & Disease;2010, Vol. 9, p78 

    Background: Non-alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis, can be reversed by early treatment. Several case reports have indicated that the administration of recombinant growth hormone (GH) could improve fatty liver in GH-deficient patients. Here, we...

  • Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma. Basyigit, Sebahat; Uzman, Metin; Kefeli, Ayse; Pirincci Sapmaz, Ferdane; Ozgür Yeniova, Abdullah; Nazligul, Yasar; Asiltürk, Zeliha // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p18601 

    Background: Colorectal carcinoma (CRC) and non-alcoholic fatty liver disease (NAFLD) share common risk factors. Insulin resistance (IR) has an important role in both diseases. It has been speculated that the prevalence of colorectal neoplasms might be increased in patients with NAFLD. However,...

  • Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. Ercin, Cemal Nuri; Dogru, Teoman; Tapan, Serkan; Karslioglu, Yıldırım; Haymana, Cem; Kilic, Selim; Sonmez, Alper; Yesilova, Zeki; Uygun, Ahmet; Gulsen, Mustafa; Bagci, Sait; Erbil, M. Kemal; Karslioglu, Yildirim; Kemal Erbil, M // Digestive Diseases & Sciences;Apr2010, Vol. 55 Issue 4, p1128 

    Nonalcoholic fatty liver disease (NAFLD) is linked to an increased risk of cardiovascular disease. We aimed to research whether the levels of soluble P-selectin (sP-selectin) and soluble CD40 ligand (sCD40L), markers of endothelial function, are altered in subjects with NAFLD having no...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics